4D Molecular Therapeutics (FDMT) Operating Margin (2020 - 2026)
4D Molecular Therapeutics (FDMT) operating margin from Mar 31, 2020 to Mar 31, 2026. The current 4D Molecular Therapeutics (FDMT) operating margin is -2413.77%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of 4D Molecular Therapeutics (FDMT)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | -187.24% | -99.96% |
| 2024 | -469600.00% | +86106.36% |
| 2023 | -544.74% | -84.50% |
| 2022 | -3515.34% | +789.06% |
| 2021 | -395.40% | -6.77% |
| 2020 | -424.10% | -41.85% |
| 2019 | -729.31% | N/A |
Comparison 4D Molecular Therapeutics (FDMT) operating margin with competitors
4D Molecular Therapeutics (FDMT) operating margin is -2413.77%.